Cocrystal Pharma Inc (COCP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,559 | -2,738 | -9,648 | -8,155 | -5,485 |
| Depreciation Amortization | 187 | 92 | 336 | 245 | 156 |
| Accounts receivable | 556 | 556 | 88 | 63 | 52 |
| Other Working Capital | 1,788 | 706 | -1,057 | 100 | 732 |
| Other Operating Activity | -366 | -386 | 451 | 298 | 157 |
| Operating Cash Flow | $-4,394 | $-1,770 | $-9,830 | $-7,449 | $-4,388 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -40 | -25 | -240 | -239 | -220 |
| Investing Cash Flow | $-40 | $-25 | $-240 | $-239 | $-220 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 38,505 | 2,072 | 35,783 | 32,161 | 16,606 |
| Other Financing Activity | -19 | -9 | -121 | -110 | -101 |
| Financing Cash Flow | $38,486 | $2,063 | $35,662 | $32,051 | $16,505 |
| Beginning Cash Position | 33,060 | 33,060 | 7,468 | 7,468 | 7,468 |
| End Cash Position | 67,112 | 33,328 | 33,060 | 31,831 | 19,365 |
| Net Cash Flow | $34,052 | $268 | $25,592 | $24,363 | $11,897 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,394 | -1,770 | -9,830 | -7,449 | -4,388 |
| Capital Expenditure | -40 | -25 | -240 | -239 | -220 |
| Free Cash Flow | -4,434 | -1,795 | -10,070 | -7,688 | -4,608 |